在儿科喘中ICS-LABA治疗的药物经济评估:成本效益和成本效益分析
1Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing, China.
Frontiers in pharmacology
|October 17, 2025
概括
对于儿科喘,多种吸入性皮质类固醇 (ICS) 和长效β-激动剂 (LABA) 疗法比单次吸入剂的长期选择更具成本效益,特别是在严重病例中. 单吸入器疗法在较轻的疾病中是可行的.
科学领域:
- 药物经济学 药物经济学
- 儿科肺病学 儿科肺病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 喘是全球儿童普遍存在的慢性呼吸道疾病.
- 吸入性皮质类固醇 (ICS) 和长效β-激动剂 (LABA) 组合疗法是儿童喘管理的标准.
- 这些方案在儿科喘中的经济可行性,特别是成本效益和成本效益,研究不足.
研究的目的:
- 评估多种ICS-LABA疗法的临床疗效与儿科喘单吸入器疗法的临床疗效.
- 评估这些治疗策略在0-18岁儿童的成本效益和成本效益.
- 为优化儿科喘管理和资源配置提供药物经济见解.
主要方法:
- 对59名儿科喘患者的回顾性研究,分为单吸入器 (A组) 和多吸入器 (B组) 治疗组.
- 通过无症状期来衡量临床疗效;药物经济分析侧重于直接的医疗成本.
- 采用成本效益分析 (CEA) 和成本效益分析 (CUA),使用基于中国人均GDP的支付意愿 (WTP) 门.
主要成果:
- 多个吸入器方案,特别是三重疗法,在复杂/扩展的儿科喘治疗中表现出优越的长期成本效益和成本效益.
- 单剂疗法在短期,不那么严重的喘中更具经济可控性,布塞尼德-形式醇显示出比萨尔米特醇-流动醇更好的成本效益.
- 使用质量调整寿命年 (QALYs) 的成本效益分析证实了多个吸入器方案的成本效益,用于长期治疗儿科喘.
结论:
- 多种ICS-LABA疗法,特别是三重疗法,在重症儿科喘中提供更好的长期成本效益.
- 单吸入器治疗对于较轻微的儿科喘病例仍然具有经济可行性.
- 结果支持个性化治疗方法和优化医疗保健资源分配在儿科喘管理.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K


